Expression of PD-L1 in Locally Advanced Breast Cancer and Its Impact on Neoadjuvant Chemotherapy Response

OBJECTIVES: Programmed cell death-ligand 1 (PD-L1) is a new target in breast cancer (BC) and its impact on neoadjuvant chemotherapy (NACTH) response is still unclear. The aim of this study was to investigate the prevalence of PD-L1 in locally advanced invasive BC of different molecular subtypes and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Mustafa A, Ismail, Hoda Abdel-Raouf, Saqr, Mona, Nouh, M Akram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587829/
https://www.ncbi.nlm.nih.gov/pubmed/35763653
http://dx.doi.org/10.31557/APJCP.2022.23.6.2095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587829/
https://www.ncbi.nlm.nih.gov/pubmed/35763653
http://dx.doi.org/10.31557/APJCP.2022.23.6.2095

Ejemplares similares